Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
For full access to this article login to GEN Select now.
Antibody Therapeutics Dominate Meeting
The Search for Cancer-Related Markers Continues
- Recombinant antibody therapeutics are moving to a next generation of products, according to a keynote address by Ronald Levy, M.D., given at IBC's recent meeting held in San Diego, "Antibody Engineering and Therapeutics." Dr. Levy is a professor of medicine at Stanford, and was responsible for one of ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.